DRC Ebola Outbreak Now Nation’s Largest Ever; Clinical Trial Of Treatment To Begin Soon

Agence France-Presse: Ebola death toll in DR Congo tops 200
“The death toll from an Ebola outbreak in eastern Democratic Republic of Congo has risen to more than 200, the health ministry said on Saturday…” (11/11).

CIDRAP News: Ebola outbreak now DRC’s largest ever, with 319 cases
“Officials [Friday] reported seven new Ebola cases in the Democratic Republic of the Congo (DRC), raising the outbreak total to 319 confirmed or probable cases, making the outbreak in North Kivu and Ituri provinces the country’s biggest in its history…” (Soucheray, 11/9).

Healio: FDA OKs emergency use of Ebola finger-stick test
“The FDA announced it has granted an emergency use authorization for a rapid, single-use test for detecting the Ebola virus that uses a portable battery-operated reader…” (Thiel, 11/9).

STAT: A pivotal day in world’s response to Ebola nears: the launch of a clinical trial
“Health officials are preparing to launch a clinical trial designed to test whether experimental Ebola therapies improve patients’ chances of survival in the outbreak in the Democratic Republic of the Congo — a landmark moment in the world’s efforts to respond to this and future crises…” (Branswell, 11/12).

Additional reporting on the DRC Ebola outbreak and response is available from Associated Press, Axios, BBC News, CBS News, Reuters, UPI, and Xinhua News.

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.